Cancer and Leukemia Group B

$237,055U10FY2013CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 35191970 Paper 33654204 Paper 31935026 Paper 31802506 Paper 30397360 Paper 30393935 Paper 30385835 Paper 29871907 Paper 29563537 Paper 29487024 Paper 29370992 Paper 29358223 Paper 29034366 Paper 28644114 Paper 28620884 Paper 28577078 Paper 28489511 Paper 28437029 Paper 28314699 Paper 28283904 Paper 28208174 Paper 28030702 Paper 26969090 Paper 26892479 Paper 26319317 Paper 26202857 Paper 26160883 Paper 26056183 Paper 25536215 Paper 25520391 Paper 25417775 Paper 25384173 Paper 25163570 Paper 24996441 Paper 24958280 Paper 24838014 Paper 24590644 Paper 24528179 Paper 24428673 Paper 24419419 Paper 24411921 Paper 24383843 Paper 24382782 Paper 24231454 Paper 24104597 Paper 24097873 Paper 24077846 Paper 24035029 Paper 23913744 Paper 23890224 Paper 23715301 Paper 23700288 Paper 23591789 Paper 23228035 Paper 23225546 Paper 23194022 Paper 23188068 Paper 23160462 Paper 23129738 Paper 23100311 Paper 22915637 Paper 22767584 Paper 22744771 Paper 22547605 Paper 22473168 Paper 22425913 Paper 22421007 Paper 22291079 Paper 22197613 Paper 22180287 Paper 22147942 Paper 22104618 Paper 22031865 Paper 21969504 Paper 21849660 Paper 21747089 Paper 21713765 Paper 21699879 Paper 21693770 Paper 21558518 Paper 21357782 Paper 21355087 Paper 21321569 Paper 21275630 Paper 21148613 Paper 20871263 Paper 20862750 Paper 20736856 Paper 20688393 Paper 20606091 Paper 20554945 Paper 20522709 Paper 20521348 Paper 20423913 Paper 20368558 Paper 20124181 Paper 20087228 Paper 19934290 Paper 19933904 Paper 19917845

Abstract

DESCRIPTION (provided by applicant): This application supports the participation of the University of Chicago in Cancer and Leukemia Group B (CALGB) trials, including scientific and regulatory activities. The CALGB develops and performs clinical trials, primarily large scale clinical trials, to advance the treatment of cancer patients. The University of Chicago is a leading member of CALGB, supplying scientific and administrative leadership including the Group Chair (Dr Schilsky), Committee Chairs (Drs Ratain, Vokes, and Larson), and Study Chairs. Preliminary studies performed at the University of Chicago are taken to CALGB for large scale testing. Laboratories at the University of Chicago perform correlative studies that support CALGB trials. University of Chicago senior faculty mentor junior faculty and fellows in cooperative group participation, with large meeting attendance and eight CALGB Foundation grants awarded to University of Chicago fellows and junior faculty during the past granting period. In addition, The University of Chicago and its eight affiliate institutions are consistently among the top five accruers to CALGB studies with broad participation across all tumor types and substantial minority accrual.

View original record on NIH RePORTER →